Clinical Trial

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Recruiting
View on ClinicalTrials.gov →
Summary
In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-01-09; most recent amendment 2023-05-30.
Status change: Not Yet Recruiting → Recruiting 2023-05-30
Trial Details
NCT Number NCT05679284
Lead Sponsor Tampere University Hospital
Collaborators: Deaconess Foundation, A-Clinic Foundation
Conditions Drug Abuse, Intravenous, Substance Dependence, Needle Injury, Soft Tissue Injuries, Foreign Bodies
Enrollment 100 participants
Start Date 2023-05-25
Primary Completion 2027-11-15 (estimated)
Study Completion 2028-11-15 (estimated)
Updated on ClinicalTrials.gov 2023-06-01